Prior Authorization Is a Numbers Game. Here's What Automation Is Actually Scoring.

Will Drewes

Founder, Fern Strategy · 3 min read

Prior Authorization Is a Numbers Game. Here's What Automation Is Actually Scoring.

Prior authorization burns physician time, delays care, and generates administrative cost that nobody defends but everyone absorbs. The question operators are actually asking in 2025: where does automation hold up under production load, and what does the evidence look like?

Four organizations have published numbers worth examining.

Allegheny Health Network processes more than 200,000 prior authorizations annually and is hitting a 96% first-pass approval rate after deploying AI-driven automation across clinical data extraction, submission, and status tracking. First-pass rate is the metric that matters most here. Every denial that comes back for rework is a physician loop, a delay, and a staff hour. At 200,000 volume, moving that rate from, say, 80% to 96% is not a marginal improvement; it's roughly 32,000 fewer rework cycles per year.

Optum reported 45% fewer manual touches and an 80% increase in processing efficiency in its digital prior authorization workflows. The system gathers required materials, applies payer rules, and submits automatically. The "fewer manual touches" metric is the one to watch. Manual touches are where errors enter, where queues form, and where staff capacity disappears into work that adds no clinical value. Cutting them by nearly half is a structural change, not a speed tweak.

WPS Health Solutions achieved a 30.27% reduction in prior authorization processing time after integrating AI into production. The same deployment covered 18 distinct use cases and processed nearly 170,000 documents annually. The 18-use-case breadth matters as much as the time reduction. A single-workflow proof of concept is easy to optimize; production performance across 18 use cases with 170,000 documents is a different claim entirely.

One authorization platform reports that up to 90% of authorization requests are approved automatically, with 85% handled in real time, across 9 million FHIR-based authorizations in the last year. This is a company-reported aggregate, so it reflects platform-wide performance rather than a single customer deployment. Still, 9 million FHIR-based authorizations is a meaningful production signal, and real-time handling at 85% changes the clinical calculus on time-sensitive cases.

What this means for health system and payer operators

Three things stand out across these cases.

First, the workflow prior auth automation targets is a textbook fit: stable rules (payer criteria don't change daily), messy inputs (unstructured clinical notes, variable documentation), and high volume. That combination is where rule-based systems break and where AI-assisted extraction and routing earns its keep.

Second, the metrics being reported are operational, not aspirational. First-pass approval rate, manual touch count, processing time, document volume. These are auditable. If a vendor or internal team can't show you the same class of metric from a pilot, that's a gap worth naming before you commit to a build.

Third, prior authorization sits at the intersection of clinical workflow and payer compliance. Any automation layer touching authorization decisions needs an audit trail, not just a dashboard. Regulators and payers both have standing to ask how a decision was made. "The model said so" is not an answer that survives a CMS audit or a denial appeal.

Fern's two-week Audit is designed for exactly this kind of workflow: high volume, rule-governed, with real compliance exposure if the automation misbehaves. The question to answer before you build is whether you have the governance foundation to stand behind the output. These four organizations apparently do. Most teams starting from scratch do not.